Trial Profile
Open Label Extension Study Evaluating the Long Term Safety, Tolerability and Efficacy of an Iron Maintenance Dosing Strategy Utilizing VIT45 in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jan 2019
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Sponsors American Regent
- 26 Jun 2014 New trial record